Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades. [electronic resource]
Producer: 20201029Description: 104444 p. digitalISSN:- 1096-0945
- Animals
- Apoptosis -- drug effects
- Caco-2 Cells
- Dexmedetomidine -- pharmacology
- Glucose -- deficiency
- Humans
- Inflammation -- pathology
- Intestines -- pathology
- MAP Kinase Signaling System -- drug effects
- Male
- Membrane Potential, Mitochondrial -- drug effects
- Mitochondria -- drug effects
- NF-kappa B -- metabolism
- Oxygen
- Protective Agents -- pharmacology
- Rats, Wistar
- Reperfusion Injury -- drug therapy
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.